WuXi AppTec Co., Ltd. (FRA:WX8)

Germany flag Germany · Delayed Price · Currency is EUR
12.20
+0.20 (1.67%)
At close: Jan 29, 2026
82.09%
Market Cap34.40B +72.5%
Revenue (ttm)5.25B +23.2%
Net Income1.79B +85.9%
EPS0.56 +53.2%
Shares Outn/a
PE Ratio19.16
Forward PE18.12
Dividend0.21 (1.67%)
Ex-Dividend DateSep 8, 2025
Volumen/a
Average Volume240
Open12.20
Previous Close12.00
Day's Range12.20 - 12.20
52-Week Range5.30 - 13.80
Betan/a
RSI48.02
Earnings DateMar 24, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Industry Commercial Physical and Biological Research
Founded 2000
Employees 37,832
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol WX8
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY Financial Statements